Clinical trials
Observational Tracheal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara Ataturk Sanatorium Training and Research Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Fudan University | 1 |
| Johns Hopkins University | 1 |
| Princess Anna Mazowiecka Hospital, Warsaw, Poland | 1 |
| Shanghai Chest Hospital | 1 |
| US Endoscopy Group Inc. | 1 |
| University College, London | 1 |
| University of Padova | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tracheal Diseases | 10 |
| Laryngeal Diseases | 2 |
| Tracheal Stenosis | 2 |
| Barrett Esophagus | 1 |
| Bronchial Diseases | 1 |
| Bronchial Neoplasms | 1 |
| Constriction, Pathologic | 1 |
| Critical Illness | 1 |
| Esophageal Neoplasms | 1 |
| Esophageal Stenosis | 1 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.